NASDAQ
23.01.26 | 22:00
21,750 US-Dollar
-3,29 % -0,740
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19:06 | Sanara MedTech expects Q4 revenue between $27.2M and $27.7M | 1 | Seeking Alpha | ||
| 13:54 | Sanara MedTech expects 19% revenue growth for 2025, issues 2026 guidance | 2 | Investing.com | ||
| 13:46 | Sanara MedTech Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 13:36 | Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance | 50 | GlobeNewswire (Europe) | FORT WORTH, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara MedTech," "Sanara," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| 07.01. | Vizient-Vertrag beflügelt Aktie von Sanara MedTech | 1 | Investing.com Deutsch | ||
| 07.01. | Sanara MedTech's BIASURGE receives Vizient innovative technology contract | 1 | Investing.com | ||
| 10.12.25 | Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic | 143 | GlobeNewswire (Europe) | Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic's granted patent in 2025 FORT WORTH, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara... ► Artikel lesen | |
| 26.11.25 | Sanara MedTech Inc. - 8-K, Current Report | - | SEC Filings | ||
| SANARA MEDTECH Aktie jetzt für 0€ handeln | |||||
| 12.11.25 | Sanara MedTech Inc. - 10-Q, Quarterly Report | 8 | SEC Filings | ||
| 12.11.25 | Sanara MedTech signals strategic shift with THP discontinuation and continued surgical growth focus | 3 | Seeking Alpha | ||
| 12.11.25 | Sanara MedTech GAAP EPS of $0.09 beats by $0.30, revenue of $26.3M misses by $0.33M | 4 | Seeking Alpha | ||
| 12.11.25 | Sanara MedTech Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.11.25 | Sanara MedTech discontinues Tissue Health Plus segment | 2 | Investing.com | ||
| 11.11.25 | Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business | 135 | GlobeNewswire (Europe) | Completes Evaluation of Strategic Alternatives for Tissue Health Plus Segment FORT WORTH, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us")... ► Artikel lesen | |
| 03.09.25 | Sanara MedTech stock falls after CEO succession announcement | 1 | Investing.com | ||
| 02.09.25 | Sanara MedTech appoints new CEO | 2 | Seeking Alpha | ||
| 02.09.25 | Sanara MedTech appoints Seth Yon as new CEO effective Sept 15 | 1 | Investing.com | ||
| 02.09.25 | Führungswechsel bei Sanara MedTech: Seth Yon wird neuer CEO | 1 | Investing.com Deutsch | ||
| 02.09.25 | Sanara MedTech Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.09.25 | Sanara MedTech Inc. Announces Chief Executive Officer Transition | 176 | GlobeNewswire (Europe) | Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," the "Company... ► Artikel lesen |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,300 | -1,84 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Siemens Healthineers vor den Zahlen zum ersten Geschäftsquartal auf "Outperform" mit einem Kursziel von 55 Euro belassen.... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,360 | -3,34 % | GOLDMAN SACHS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Carl Zeiss Meditec von 54 auf 42 Euro gesenkt und die Aktien von "Buy" auf "Neutral" abgestuft. Analyst Richard... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,220 | -0,72 % | Elmos, FMC, Gerresheimer, Hensoldt, Hypoport, Zalando: Neue Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| MOVANO | 16,740 | +140,17 % | Morning Market Movers: Movano, Direct Digital Holdings, Ryvyl, Erayak Power Solution See Big Swings | SANTA CLARA (dpa-AFX) - At 7:40 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| FRESENIUS | 48,370 | -0,21 % | Fresenius: Megatrend KI - Partnerschaft mit SAP | Der Gesundheitskonzern Fresenius geht die nächste Zusammenarbeit im Bereich der Künstlichen Intelligenz (KI) ein. Nachdem die Gesellschaft über mAbxience bereits Anfang Dezember eine Partnerschaft mit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,640 | +0,13 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 101,35 | -0,52 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,810 | +0,76 % | Alignment Healthcare stock price target raised to $28 by KeyBanc | ||
| PROGYNY | 25,220 | +0,92 % | Forecasting The Future: 6 Analyst Projections For Progyny | ||
| PROCEPT BIOROBOTICS | 29,130 | -5,33 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HEARTFLOW | 32,160 | -3,91 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,340 | -0,27 % | Analysts Turn More Bullish on LifeStance Health Group (LFST) After Dual Price Target Hikes | ||
| ADAPTHEALTH | 10,090 | -3,90 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| GERRESHEIMER | 27,100 | -0,73 % | Analysten-Hype bei Gerresheimer: Springt die Aktie jetzt richtig an? | ||
| CLEARPOINT NEURO | 15,680 | +10,34 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen |
SANARA MEDTECH INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,740 (-3,29 %) liegt der Kurs bei 21,750 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SANARA MEDTECH INC finden Sie auf Wallstreet Online.